Impact of Using a Non-Rebreathing Mask in Patients With Respiratory Failure

• Published in: The American journal of the medical sciences 2021-04, Vol.361 (4), p.436-444
• Main Authors: Li, Chao-Jui, Law, Yat-Yin, Lin, Yan-Ren, Chen, Chien-Chih, Lin, Xin-Hong, Chuang, Po-Chun
• Format: Article
• Language: English
• Subjects: Adolescent; Adult; Aged; Aged, 80 and over; Female; High-concentration oxygen therapy; Humans; Male; Masks - statistics & numerical data; Middle Aged; Mortality; Non-rebreathing mask; Oxygen Inhalation Therapy - instrumentation; Oxygen Inhalation Therapy - methods; Respiration, Artificial - instrumentation; Respiration, Artificial - methods; Respiratory failure; Respiratory Insufficiency - therapy; Retrospective Studies; Taiwan; Young Adult
• ISSN: 0002-9629; 1538-2990
• DOI: 10.1016/j.amjms.2020.12.010

Liberal oxygen therapy might increase the mortality rate of patients. Non-rebreathing masks (NRM) are a high-flow, non-invasive oxygen device that can provide oxygen concentration up to 95%. This study aimed to determine the impact of using NRM in patients with respiratory failure. This retrospective cohort study was conducted in four medical institutions in Taiwan from January 2010 to December 2016. The association between mortality and NRM use before receiving ventilator support in patients with respiratory failure in the emergency department was analyzed. Patients were divided into the NRM treatment and no NRM treatment groups. A 1:4 propensity score matching was conducted. Regarding the duration of NRM use, treatments were grouped as 0 h, 0–1 h, 1–2 h, and >2 h. A total of 18,749 patients were included, with 1074 using NRM. After propensity score matching, 1028 patients using NRM (0–1 h: 508, 1–2 h: 193, and >2 h: 327) and 4112 patients not using NRM were analyzed. The 30-day mortality rates were 29.1%, 28.5%, 27.5%, and 35.5% in the 0 h, 0–1 h, 1–2 h, and >2 h treatment groups, respectively. Patients with respiratory failure due to pulmonary disease using NRM over 2 h had a higher mortality rate than patients not using NRM (hazard ratio: 1.3, 95% CI: 1.01–1.66). Prolonged use of NRM in patients with respiratory failure due to pulmonary disease possibly increases mortality.